Members: Standard Members

At B&D Consulting (a division of the law firm of  Baker & Daniels LLP), our professionals have decades of experience with reimbursement, advocacy, science policy and regulatory issues. From start-up to Fortune 500 companies, our health & life sciences team provides a full range of integrated business consulting and legal services.

Gov't Affairs and Corp. Communications Research and Consulting

Venture Capital Firm

Consulting Services

Legal / Litigation

Legal / Health Care Consulting

Research and private equity specialists in orthopedics

HillCo HEALTH, a boutique group of seasoned principals, provides advisory services including strategic policy planning, implications and solution, reimbursement and coding insights and strategies and payor advocacy for leading health care delivery, financing, manufacturing, and service entities.

Federal affairs and political strategy

Reimbursement consulting

Medical Device reimbursement - strategy/implementation

Healthcare advisory and financial services firm

Engineering / Design / Product Development

Reimbursement consulting

Venture Capital Firm

Private payer reimbursement and coverage issues

Reimbursement consulting

Reimbursement Strategies, LLC provides a comprehensive range of healthcare policy and reimbursement device technology consulting services-Pre-FDA-approval and Post-FDA-approval -- for emerging and established companies. We assist and guide medical device and diagnostic companies during business development in gaining an educated, competitive advantage by increasing their understanding surrounding the complexity of the insurance reimbursement process. Reimbursement Strategies provides strategic and tactical coverage and reimbursement consulting services during product development and after product launch.

The firm's core purpose is to create innovative solutions to complex healthcare technologies and services, to facilitate increased patient access to products that increase and benefit their quality of life.

Strategy/Execution: Minimally Invasive Devices

SV Life Sciences is a leading international life sciences venture capital firm. SVLS affiliated funds have been investing in life sciences companies since the early 1980s and the firm closed its first dedicated life sciences fund in 1994. The SVLS team manages six venture capital funds and a publicly traded investment trust with approximately $2 billion of capital under management. The firm employs a diversified strategy within life sciences in order to selectively capitalize on an expanding opportunity in biotech, medical devices and health-care services. SVLS has offices in Boston, London and San Francisco.

Venture Capital Firm